FDC BAN: HASTE MAKES WASTE?

Reacting strongly against the ban on 344 FDC drugs, industry veterans call it a hasty decision and question the government’s…

A portal for progress?

It is only five months since India’s central drug authority launched its online licensing services portal, SUGAM. But the regulator…

In Need of Renewed Focus

Pharma MSMEs will miss the Make in India bus unless they upgrade to global norms. But industry stalwarts point out…

Building Healthy Workplaces

Awakening to the need for a healthy workforce to build successful businesses, pharma firms are introducing a slew of measures…